| P2093 | author name string | Wenlong Zhang | |
| | Tao Zhang | |
| | Juan Chen | |
| | Xiaolong Zhu | |
| | Chengwei Zou | |
| | Haiyan Jing | |
| | Ningning Rong | |
| P2860 | cites work | Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells | Q46709814 |
| | [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue] | Q68175965 |
| | Chemotherapy of advanced NSCLC in the elderly | Q78044342 |
| | Chemotherapy: Effectiveness of adjuvant chemotherapy for resected NSCLC | Q82083726 |
| | SirT1 confers hypoxia-induced radioresistance via the modulation of c-Myc stabilization on hepatoma cells | Q83388812 |
| | Galectin-3 genetic variants are associated with platinum-based chemotherapy response and prognosis in patients with NSCLC | Q83812642 |
| | Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer | Q84283695 |
| | Hormonal control of androgen receptor function through SIRT1 | Q24672448 |
| | The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth | Q33328513 |
| | How does SIRT1 affect metabolism, senescence and cancer? | Q33802917 |
| | SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas | Q34425251 |
| | MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1 | Q34733682 |
| | Chemotherapy in NSCLC: historical review | Q35017953 |
| | 75-kd sirtuin 1 blocks tumor necrosis factor α-mediated apoptosis in human osteoarthritic chondrocytes | Q35718396 |
| | Pharmacogenomics of platinum-based chemotherapy in NSCLC | Q36158678 |
| | DBC1 does not function as a negative regulator of SIRT1 in liver cancer | Q36403176 |
| | SIRT1 and energy metabolism | Q36479802 |
| | The biochemistry of sirtuins. | Q36498332 |
| | Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice | Q37097951 |
| | Sirtuin 1, stem cells, aging, and stem cell aging | Q37184335 |
| | The role of sirtuin proteins in obesity | Q37206732 |
| | Roles of SIRT1 in leukemogenesis | Q37256768 |
| | SIRTUIN 1: regulating the regulator | Q37262086 |
| | SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells | Q37339713 |
| | Staging of non-small cell lung cancer (NSCLC): a review | Q37787515 |
| | Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy | Q37833232 |
| | Sirtuin 1 in immune regulation and autoimmunity | Q37959305 |
| | Sirt1: def-eating senescence? | Q38043910 |
| | Lung cancer biomarkers: State of the art. | Q38100160 |
| | Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma | Q38479914 |
| | Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice | Q39198979 |
| | SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice | Q39370330 |
| | High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells. | Q39398709 |
| | SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis | Q39432222 |
| | The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours | Q39512984 |
| | Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression | Q39891403 |
| | Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: implications for predictive testing. | Q40036508 |
| | SIRT1 is significantly elevated in mouse and human prostate cancer. | Q40105577 |
| | Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells | Q40108455 |
| | Role of NAD-dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin-induced cell death in vertebrate cells. | Q40445696 |
| | Anti-aging protein SIRT1: a role in cervical cancer? | Q42109572 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | e79162 | |
| P577 | publication date | 2013-11-05 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | SIRT1 expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLC. | |
| P478 | volume | 8 | |